Rivero-Juarez, A., López-Cortés, L. F., Camacho, A., Torres-Cornejo, A., Gordon, A., Ruiz-Valderas, R., . . . Rivero, A. (2014). HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients. Public Library of Science.
Citação norma ChicagoRivero-Juarez, Antonio, et al. HCV Viral Decline At Week 2 of Peg-IFN-Alpha-2a/RBV Therapy As a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients. Public Library of Science, 2014.
Citação norma MLARivero-Juarez, Antonio, et al. HCV Viral Decline At Week 2 of Peg-IFN-Alpha-2a/RBV Therapy As a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients. Public Library of Science, 2014.